Get started
Author

Veli Kairisto

Observed names: Kairisto, Kairisto, V., Kairisto, Veli, V Kairisto, V. Kairisto, Veli S Kairisto
Observed institutions: University of Helsinki, University of Turku, Oulu University Hospital, Helsinki University Hospital, Turku University Hospital, University of Oulu
ORCID: 0000-0002-0562-8054
Observed ORCID: 0000-0002-0562-8054
OpenAlex ID: A5090910971
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial
2018 · Susanne Saussele, Johan Richter, et al. · The Lancet Oncology · 627
PDF
The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties
2004 · P. Rustad, P. Felding, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 407
Reference Intervals for Serum Creatinine Concentrations: Assessment of Available Data for Global Application
2008 · Ferruccio Ceriotti, James C Boyd, et al. · Clinical Chemistry · 252
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
2011 · Bengt Simonsson, Tobias Gedde-Dahl, et al. · Blood · 194
PDF
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study
2009 · Michele Baccarani, Gianantonio Rosti, et al. · Blood · 191
Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy
2010 · Anna Kreutzman, Vesa Juvonen, et al. · Blood · 173
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA
2010 · Helen E. White, Paul Matejtschuk, et al. · Blood · 161
Rapid Identification of Apolipoprotein E Genotypes by Multiplex Amplification Refractory Mutation System PCR and Capillary Gel Electrophoresis
1999 · Gerard G Donohoe, Anne Salomäki, et al. · Clinical Chemistry · 118
A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries
2004 · G. Nordin, A. Mårtensson, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 101
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1
2019 · H. Pfeifer, G. Cazzaniga, et al. · Leukemia · 82
A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR
2014 · H White, L Deprez, et al. · Leukemia · 79
PDF
Reference intervals developed from data for hospitalized patients: computerized method based on combination of laboratory and diagnostic data
1994 · T Kouri, V Kairisto, et al. · Clinical Chemistry · 72
The occurrence of dominant spinocerebellar ataxias among 251 Finnish ataxia patients and the role of predisposing large normal alleles in a genetically isolated population
2005 · V. Juvonen, M. Hietala, et al. · Acta Neurologica Scandinavica · 70
Outcome of Traumatic Brain Injury after Three Decades— Relationship to ApoE Genotype
2006 · Heli Isoniemi, Olli Tenovuo, et al. · Journal of Neurotrauma · 66
APOE -ε4 predicts dementia but not other psychiatric disorders after traumatic brain injury
2004 · S. Koponen, T. Taiminen, et al. · Neurology · 63
Regression-based reference limits: determination of sufficient sample size
1998 · Arja Virtanen, Veli Kairisto, et al. · Clinical Chemistry · 63
Cessation of Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid Leukemia Patients with Deep Molecular Response: Results of the Euro-Ski Trial
2016 · Francois-xavier Mahon, Johan Richter, et al. · Blood · 62
Interim Analysis of a Pan European Stop Tyrosine Kinase Inhibitor Trial in Chronic Myeloid Leukemia : The EURO-SKI study
2014 · Francois-Xavier Mahon, Johan Richter, et al. · Blood · 54
Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-α Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile
2011 · Anna Kreutzman, Peter Rohon, et al. · PLoS ONE · 51
PDF
Depth of response assessed by quantitative ASO‐PCR predicts the outcome after stem cell transplantation in multiple myeloma
2010 · Mervi Putkonen, Veli Kairisto, et al. · European Journal Of Haematology · 49
Regression-based reference limits and their reliability: example on hemoglobin during the first year of life.
1998 · A Virtanen, V Kairisto, et al. · PubMed · 44
Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury
2006 · H. Isoniemi, T. Kurki, et al. · Neurology · 43
Reference individuals, blood collection, treatment of samples and descriptive data from the questionnaire in the Nordic Reference Interval Project 2000
2004 · P. Felding, P. Rustad, et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 43
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
2022 · Helen E. White, Matthew Salmon, et al. · Leukemia · 40
Association of injury severity, MRI-results and ApoE genotype with 1-year outcome in mainly mild TBI: A preliminary study
2009 · Heli Hiekkanen, Timo Kurki, et al. · Brain Injury · 40
Works count: 80
Citation count: 3,825
H-index: 31
I10-index: 53
Year
Topic
Type